성인 기관지확장증 약물치료의 최신지견
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Hayoung | - |
dc.contributor.author | Lee, Hyun | - |
dc.contributor.author | Ra, Seung Won | - |
dc.contributor.author | Oh, Yeon-Mok | - |
dc.date.accessioned | 2021-08-02T08:53:37Z | - |
dc.date.available | 2021-08-02T08:53:37Z | - |
dc.date.created | 2021-05-11 | - |
dc.date.issued | 2020-08 | - |
dc.identifier.issn | 1975-8456 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/9050 | - |
dc.description.abstract | Bronchiectasis refers to abnormal dilatation of the bronchi, which leads to the failure of mucus clearance and increased risk of infection. Pharmacotherapy for stable bronchiectasis includes oral or inhaled mucoactive agents, anti-inflammatory therapy, inhaled bronchodilators, long-term antibiotics, and long-term macrolide treatment. Among them, mucoactive agents are the most common adjunctive agents to airway clearance techniques. When patients with impaired lung function suffer from dyspnea, inhaled bronchodilators may be prescribed to relieve the symptom. Long-term macrolide treatment has been proven to prevent exacerbation in patients with frequent bronchiectasis exacerbation. If exacerbation occurs despite the above mentioned treatments, one or two weeks of antibiotics should be prescribed to cover respiratory bacteria that include Pseudomonas aeruginosa. Because evidence supporting the use of pharmacotherapy for bronchiectasis is weak, further research is warranted. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | KOREAN MEDICAL ASSOC | - |
dc.title | 성인 기관지확장증 약물치료의 최신지견 | - |
dc.title.alternative | Update on pharmacotherapy for adult bronchiectasis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Hyun | - |
dc.identifier.doi | 10.5124/jkma.2020.63.8.486 | - |
dc.identifier.scopusid | 2-s2.0-85091440261 | - |
dc.identifier.wosid | 000563011400008 | - |
dc.identifier.bibliographicCitation | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, v.63, no.8, pp.486 - 492 | - |
dc.relation.isPartOf | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION | - |
dc.citation.title | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION | - |
dc.citation.volume | 63 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 486 | - |
dc.citation.endPage | 492 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002614898 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | GUIDELINES | - |
dc.subject.keywordPlus | EXACERBATIONS | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | TRIAL | - |
dc.subject.keywordAuthor | Bronchiectasis | - |
dc.subject.keywordAuthor | Pharmacotherapy | - |
dc.subject.keywordAuthor | Therapeutics | - |
dc.identifier.url | https://jkma.org/journal/view.php?doi=10.5124/jkma.2020.63.8.486 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.